Thermo Fisher Scientific Inc. and First Genetics JCS formed a collaborative partnership focused on commercializing next-generation sequencing (NGS)-based diagnostics in Russia.
Merck KGaA plans to build a new USD 19.96 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 2725
Published Date: May 01, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing need amongst researchers and laboratory analysts to reduce the contamination during the extraction and isolation process of proteins, is one of the major factors that is driving the growth of the market.
The market is anticipated to attain a CAGR of 8.65% over the forecast period, i.e. 2023-2035.
High costs of instruments and tools that are required for the extraction and isolation processes of proteins is one of the major factors anticipated to act as a barrier towards the growth of the global and southeast Asia protein purification & isolation market.
The market in Europe is anticipated to display significant business opportunities in the future.
The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, Sigma-Aldrich Co., QIAGEN GmbH, Bio-Rad Laboratories, Inc., Agilent Technologies, General Electric Company, Abcam plc and F. Hoffmann-La Roche Ltd.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is majorly segmented by product, technology and by region.
The kits segment, which is a sub-segment of the consumables segment under product segment, held the largest market share of 29.27% in the year 2019 and is anticipated to display significant growth opportunity.